Large-Cap Stocks Rally on Earnings Beat and Corporate Actions

BenzingaBenzinga
|||1 min read
Key Takeaway

Large-cap stocks rallied on strong earnings and corporate actions. First Majestic Silver led with 25% gains, joined by Moderna and Global Payments on positive results.

Large-Cap Stocks Rally on Earnings Beat and Corporate Actions

A diverse group of large-cap equities delivered substantial gains during the week of February 16-20, driven primarily by better-than-expected quarterly earnings results and strategic corporate announcements. First Majestic Silver led the cohort with a 25.23% weekly gain following the release of fourth-quarter results that exceeded analyst expectations. The precious metals producer was joined by gains in Moderna (19.68%), which advanced following FDA activity related to its seasonal influenza vaccine program, and Global Payments (19.52%), which posted strong fourth-quarter earnings while simultaneously announcing a $2.6 billion share repurchase authorization.

Additional performers in the large-cap segment included Coinbase, which gained 11.32%, along with companies such as Omnicom, Garmin, Figma, and Pan American Silver, all of which reported quarterly results and forward guidance that met or exceeded market expectations. The broad-based strength across multiple sectors and company sizes suggests investor confidence in earnings quality and corporate capital allocation decisions during what has been an active earnings season.

Investors reviewing portfolio positioning may want to assess whether their holdings align with this recent market momentum, particularly among companies that have demonstrated earnings resilience and shareholder-friendly capital deployment strategies.

Source: Benzinga

Back to newsPublished Feb 22

Related Coverage

The Motley Fool

Circle Internet Stock Plummets 20% on Draft Stablecoin Yield Restrictions

Circle Internet shares crashed 20% on draft legislation threatening stablecoin yield restrictions, threatening the company's core revenue model.

NUCRCLCOIN
GlobeNewswire Inc.

Pomerantz Files Securities Fraud Suit Against $INO Over FDA Approval Misstatements

Pomerantz LLP sues Inovio Pharmaceuticals for alleged securities fraud over FDA approval misstatements. Stock fell 3.1% and 24.45% following manufacturing delays and accelerated approval rejection.

INO
Benzinga

Abivax Dismisses M&A Speculation, Plans Capital Raise Before Trial Readout

Abivax CEO dismisses acquisition rumors, plans equity and debt raise after Phase 3 obefazimod data in Q2 2026. $614.42M cash runway supports strategy.

LLYAZNABVX
GlobeNewswire Inc.

Based Eggman Introduces Staking as Memecoin Market Pivots Toward Utility

Based Eggman launches staking in Stage 3 presale, raising 311,000 USDT with 40M tokens sold. The utility-focused memecoin combines gaming and creator monetization on Coinbase's Base blockchain.

COIN
GlobeNewswire Inc.

Corcept Faces Class Action Over Relacorilant Claims as Investors Allege Misleading Trial Data

Class action lawsuit filed against $COPT alleging executives misrepresented relacorilant clinical trial strength and FDA approval prospects, harming investors.

CORT
The Motley Fool

Lenz Therapeutics Stock Crashes 11.2% on Missed Earnings and Weak VIZZ Launch

Lenz Therapeutics stock plummeted 11.2% after Q4 earnings miss, larger-than-expected losses, and disappointing VIZZ prescription uptake despite strong pipeline projections.

LENZ